Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
|Live BSE Quotes||Sep 29, 2016 (Close)|
|Price (Rs)825.05||Open (Rs) 874.90||High (Rs) 879.00||Low (Rs) 782.00|
|% Change-4.98||Volume 309,538||Value (Rs) 258,286,704||52-Week H/L 891.50 / 582.00|
|Live NSE Quotes||Sep 29, 2016 (Close)|
|Price (Rs)825.25||Open (Rs) 876.00||High (Rs) 876.50||Low (Rs) 784.35|
|% Change-5.07||Volume 4,591,243||Value (Rs) 3,835,629,336||52-Week H/L 891.50 / 582.00|
|EPS (Rs)* 37.19||P/E Ratio (x) 22.18||Market Cap (Rs m) 480,938.15||P/BV (x) 6.82|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|AUROBINDO PHARMA Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.
Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.
Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.
Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.
Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.More Views on News
Sooner or later, the recovery myth will explode...
The three words that made the biggest contribution to Warren Buffett's enormous wealth.
Structured Debt Restructuring not a cakewalk for banks.
Asad Dossani discusses an experience that helped him control his emotions while trading. It takes years of hard work, but over time you can reduce your emotional reaction to trading losses. This improves your performance and reduces the stress you often experience as a trader
PersonalFN explains why instead of focusing merely on how much your fund manager earns, a holistic assessment is imperative to select mutual funds prudently for your investment portfolio.More